Pack Size/Qty | Price | Unit Price | |
6 Inhaler/s | $126.00 | $21.05 | |
3 Inhaler/s | $64.50 | $21.50 | |
1 Inhaler | $26.00 | $26.00 |
Generic Name : Formoterol Fumarate and Budesonide
Brand Name : Aerosol Inhale
Manufacturer Name : Cipla Ltd - Pharmaceutical Company
Product Code : CRX 178
Delivery Days : 10 to 15 working days
Strength : 12/400
Packaging : Inhaler
Prescribed For : Increased Heartrates, Nausea
Foracort Forte 12/400mcg Inhaler is a pharmaceutical marvel that plays a pivotal role in managing respiratory conditions, particularly asthma and chronic obstructive pulmonary disease (COPD). This inhaler combines two potent active ingredients, formoterol and budesonide, in a carefully calibrated formulation to provide effective relief for individuals grappling with respiratory challenges. In this comprehensive overview, we delve into the intricate details of Foracort Forte 12/400mcg Inhaler, exploring its composition, mechanism of action, therapeutic indications, dosage, potential side effects, and other relevant aspects.
Foracort Forte 12/400mcg Inhaler is a combination inhaler that contains two main active ingredients: formoterol and budesonide. Formoterol is a long-acting beta2-adrenergic agonist (LABA), while budesonide is a corticosteroid. The synergistic combination of these two compounds addresses both the bronchoconstrictive and inflammatory components of respiratory conditions.
Formoterol acts by stimulating beta2-adrenergic receptors in the airways, resulting in bronchodilation. This mechanism helps to alleviate the constriction of the air passages, allowing for improved airflow. On the other hand, budesonide, a corticosteroid, exerts its anti-inflammatory effects by inhibiting the production of inflammatory mediators and reducing the activity of immune cells involved in the inflammatory response. The combination of these two agents provides a comprehensive approach to managing respiratory conditions.
Foracort Forte 12/400mcg Inhaler is primarily indicated for the long-term management of asthma and COPD in adults. Asthma is a chronic inflammatory condition characterized by bronchoconstriction and airway inflammation, leading to symptoms such as wheezing, shortness of breath, and coughing. COPD, which includes chronic bronchitis and emphysema, is characterized by progressive airflow limitation and persistent respiratory symptoms.
The use of Foracort Forte 12/400mcg Inhaler is generally recommended for patients whose symptoms are not adequately controlled by a single medication. The combination of a LABA and an inhaled corticosteroid provides a more comprehensive and effective approach to managing both the bronchoconstrictive and inflammatory components of these respiratory conditions.
The dosage of Foracort Forte 12/400mcg Inhaler is individualized based on the severity of the patient's condition and their response to treatment. It is crucial to follow the prescribed dosage and administration instructions provided by the healthcare provider. The inhaler is typically used twice daily, with each dose delivering 12 micrograms of formoterol and 400 micrograms of budesonide.
The inhaler should be shaken well before each use to ensure proper dispersion of the medication. Patients are advised to exhale completely before inhaling the medication, and after inhalation, they should hold their breath for a few seconds to allow for optimal drug deposition in the lungs.
Side Effects:-
While Foracort Forte 12/400mcg Inhaler is generally well-tolerated, like any medication, it may cause side effects in some individuals. Common side effects include headache, throat irritation, cough, and oral thrush (a fungal infection in the mouth). These side effects are usually mild and transient.
It's important for patients to be aware of potential serious side effects, such as an increased risk of pneumonia, paradoxical bronchospasm (a sudden and severe narrowing of the airways), and systemic effects associated with corticosteroid use. Any unusual or severe symptoms should be promptly reported to the healthcare provider.
Certain precautions should be considered before initiating treatment with Foracort Forte 12/400mcg Inhaler. It is contraindicated in patients with hypersensitivity to any of its components. Additionally, caution is advised in patients with cardiovascular disorders, as LABAs like formoterol may increase the risk of cardiovascular events.
Special consideration should be given to patients with a history of tuberculosis, as corticosteroids can reactivate latent tuberculosis. Regular monitoring of lung function and clinical status is recommended to ensure optimal therapeutic outcomes.
Foracort Forte 12/400mcg Inhaler stands as a beacon of hope for individuals grappling with asthma and COPD, providing a powerful combination of formoterol and budesonide to address the multifaceted nature of these respiratory conditions. As with any medication, it is imperative for healthcare providers and patients alike to collaborate closely, considering individual needs, response to treatment, and potential side effects.
This inhaler, with its dual-action mechanism, exemplifies the progress in respiratory medicine, offering a comprehensive solution that goes beyond symptomatic relief to address the underlying inflammatory processes. As research and development in the field of respiratory medicine continue, Foracort Forte 12/400mcg Inhaler stands as a testament to the ongoing pursuit of effective and patient-centric solutions for individuals navigating the challenges of respiratory diseases.